Michele Kearney's Nuclear Wire: Intranasal influenza vaccine spurs strong immune response in Phase 1 study | National Institutes of Health (NIH)

Michele Kearney's Nuclear Wire

Michele Kearney's Nuclear Wire - Major Energy and Environmental News and Commentary affecting the Nuclear Industry. Nuclear Activities

Wednesday, February 3, 2021

Intranasal influenza vaccine spurs strong immune response in Phase 1 study | National Institutes of Health (NIH)

Intranasal influenza vaccine spurs strong immune response in Phase 1 study | National Institutes of Health (NIH): The vaccine platform could be highly adaptable for use against other viruses.

Michele Kearney at 1:43 PM

No comments:

Post a Comment

View web version

Powered by Blogger.